InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the full record of transactions filed by MOYES JAY M, Director. Insider active across 2 companies, notably Puma Biotechnology, INC.. In total, 8 disclosures have been logged. Total volume traded: €529k. The latest transaction was disclosed on 16 June 2022 — Cession. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations8 total
€57,24022,858 shares@ €2.50420.016% mcap10.8% of flow
Common Stock
SEC:0001437749-22-015524:0·
027,000 shares0
Common Stock
SEC:0001437749-22-015294:0·
2,455 shares
Class A Common Stock
SEC:0001104659-21-094520·
2,455 shares
Class A Common Stock
SEC:0001104659-21-094520:0·
027,858 shares0
Common Stock
SEC:0001209191-21-041706·
027,858 shares0
Common Stock
SEC:0001209191-21-041706:0·
€235,66125,248 shares@ €9.33390.067% mcap100.0% of flow
Common Stock
SEC:0001209191-21-039954·
€235,66125,248 shares@ €9.33390.067% mcap44.6% of flow
Common Stock
SEC:0001209191-21-039954:0·
8 of 8 declarations
About MOYES JAY M
MOYES Jay M serves as a Board Member and Chief Financial Officer of Puma Biotechnology, Inc. and Sera Prognostics, Inc. He plays a key role in overseeing the finances and strategy of the companies, ensuring transparency and financial accountability. His financial expertise is an asset to the boards.
